# AJANTPHARM — Ajanta Pharma Limited

> Ajanta Pharma Limited (AJANTPHARM) on the NSE: 6,516 sessions of split-adjusted history from 2000.

Canonical: https://patternsradar.com/s/AJANTPHARM

## Latest session

- Close: 3,639.8 INR (-0.51% on the day), 2026-08-21
- Delivery: 48.12% of volume taken to demat (20-day average 47.2%)
- Volume: 51.8K shares, turnover ₹18.9Cr
- Relative volume: 0.47× of its own 20-day average

## Technicals

- RSI(14): 62.05
- ATR(14): 102.82
- SMA 50: 3,398.8, SMA 200: 2,963.94
- 52-week range: 2,329.9 – 3,796 (-4.11% from the high)

## Performance

- 1 week -0.9%, 1 month 5.81%, 3 months 17.13%
- 6 months 23.8%, 1 year 36.24%

## Fundamentals

- Market cap: 45,482.6 crore
- P/E (TTM): 40.08 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 90.82 INR, split-adjusted to match the price series
- Revenue growth: 24.82% YoY, 14.37% QoQ
- Profit growth: 30.89% YoY, 25.32% QoQ

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 1,186.6 | 915.9 | 290.2 | 216.5 | 17.27 | 18.24% |
| 2024-12-31 | 1,146.1 | 869.2 | 307.4 | 232.9 | 18.6 | 20.32% |
| 2025-03-31 | 1,170.4 | 919.1 | 269.4 | 225.3 | 18 | 19.25% |
| 2025-06-30 | 1,302.7 | 997.9 | 331.1 | 255.3 | 20.44 | 19.6% |
| 2025-09-30 | 1,353.7 | 1,072.3 | 340.8 | 260.2 | 20.83 | 19.22% |
| 2025-12-31 | 1,374.8 | 1,041.2 | 358.6 | 273.8 | 21.91 | 19.91% |
| 2026-03-31 | 1,421.6 | 1,136 | 347.1 | 266.7 | 21.35 | 18.76% |
| 2026-06-30 | 1,626 | 1,250.1 | 446.8 | 334.2 | 26.75 | 20.56% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 63.48%
- Public: 36.52%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-08-05: dividend
- 2026-07-30: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_180517_30072026154114_iXBRL_WEB.html
- 2026-07-14: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1692098_14072026024314_WEB.xml
- 2026-05-05: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_155581_05052026164747_iXBRL_WEB.html
- 2026-04-13: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1649511_13042026112752_WEB.xml
- 2026-01-30: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_139073_30012026160055_iXBRL_WEB.html
- 2026-01-12: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1598406_12012026114131_WEB.xml
- 2025-11-10: dividend

Dated by the day the company broadcast the filing. 132 events are indexed for this instrument.

## About the instrument

- Listed: 2000-06-05 — latest session 2026-08-21 (6,516 sessions)
- ISIN: INE031B01049
- Series: EQ
- Liquidity rank: #538 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/AJANTPHARM.